Publications by authors named "Kyoung Mii Park"

Computational techniques for predicting interactions of proteins and druglike molecules have often been used to search for compounds that bind a given protein with high affinity. More recently, such tools have also been applied to the reverse procedure of searching protein targets for a given compound. Among methods for predicting protein-ligand interactions, ligand-based methods relying on similarity to ligands of known interactions are effective only when similar protein-ligand interactions are known.

View Article and Find Full Text PDF
Article Synopsis
  • There is a lack of integrated databases for Traditional Korean Medicine (TKM) that support drug discovery, which led to the creation of PharmDB-K.
  • PharmDB-K provides extensive data on TKM-related drugs, disease indications, and protein interactions, built from numerous sources including databases, Pharmacopoeias, and literature.
  • The database currently holds detailed information on 262 TKM products, over 7,800 drugs, 3,700 diseases, and also features specialized tools like phExplorer and BioMart for efficient navigation and analysis of the TKM network.
View Article and Find Full Text PDF

Mammalian cells have cytoplasmic and mitochondrial aminoacyl-tRNA synthetases (ARSs) that catalyze aminoacylation of tRNAs during protein synthesis. Despite their housekeeping functions in protein synthesis, recently, ARSs and ARS-interacting multifunctional proteins (AIMPs) have been shown to play important roles in disease pathogenesis through their interactions with disease-related molecules. However, there are lacks of data resources and analytical tools that can be used to examine disease associations of ARS/AIMPs.

View Article and Find Full Text PDF

Background: Anticancer therapies that target single signal transduction pathways often fail to prevent proliferation of cancer cells because of overlapping functions and cross-talk between different signaling pathways. Recent research has identified that balanced multi-component therapies might be more efficacious than highly specific single component therapies in certain cases. Ideally, synergistic combinations can provide 1) increased efficacy of the therapeutic effect 2) reduced toxicity as a result of decreased dosage providing equivalent or increased efficacy 3) the avoidance or delayed onset of drug resistance.

View Article and Find Full Text PDF